Home > News Item Detail
Headache in the News ArchiveMAP Pharmaceuticals -- MAP Pharmaceuticals Phase 3 Trial of Levadex (TM) Migraine Product Candidate Meets Four Endpoints
2009 May 26 MAP Pharmaceuticals Phase 3 Trial of LEVADEX (TM) Migraine Product Candidate Meets All Four Primary Endpoints
http://ir.mappharma.com/ReleaseDetail.cfm?ReleaseID=385799 Categories: Research |
Find a headache specialist near you:
From NHF HeadLines
Take Control of Your Headaches - Issue 175
NHF Features